Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
The 12-month alpha-testing phase will bring together ZEISS R&D, three academic collaborators, and three pharmaceutical industry partners
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Subscribe To Our Newsletter & Stay Updated
